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Iron is an essential element for almost all living organisms. Tissue iron 
concentration shows natural variations among individuals, because of the influence of 
both environmental and genetic factors. Body iron, though essential, is also toxic in 
excess by generating reactive oxygen species. Iron homeostasis, thus, must be maintained 
systemically by the rate of iron absorption, iron utilization, iron storage and the rate of 
iron recycling. It is possible that mutations in any of the genes that encode proteins 
involved in maintaining iron homeostasis have the potential to alter iron load. The effect 
of single nucleotide polymorphisms (SNPs), a major genetic factor, on beef iron content 
were investigated in the current study. 
The first objective of this study was to determine the variation of iron content in 
bovine longissimus dorsi (LD) muscle. The second objective was to identify single 
nucleotide polymorphisms (SNPs) in the exons and their flanking regions of the bovine 
ferroportin gene (Fpn) and to evaluate the association between the identified SNPs and 
bovine muscle iron content. LD muscle samples were collected from 1086 Angus cattle 
for iron quantification and genomic DNA extraction. Nine exons and their flanking 
regions of Fpn were amplified and sequenced with 6 selected DNA samples. Genotyping 
was carried out for 1086 cattle. Nine novel SNPs, NC007300: g.1780 A>G, g.1872 A>G, 
g.7169 C>T, g.7477 C>G, g.19208 C>T, g.19263 A>G, g.19427 A>G, g.19569 C>T and 
g.20480 C>T, were identified. Statistical analysis showed that three of the nine SNPs, 
g.19208 C>T, g.19263 A>G, and g.20480 C>T, were significantly (P < 0.007) associated 
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with muscle iron content. High linkage disequilibrium was observed for SNP g.19208 
C>T, g. 19263 A>G and g. 20480 C>T (R2 > 0.99), with which two haplotypes, TGC and 
CAT, were defined. Beef from individuals that were homozygous for the TGC haplotype 
had significantly (P < 0.001) higher iron contents than did beef from CAT homozygous or 
heterozygous individuals. 
In conclusion, results of the current study indicated that SNPs, NC007300: 
g.19208 C>T, g.19263 A>G, and g.20480 C>T, in Fpn might be useful markers for the 
selection of Angus cattle that produce progeny with a more desirable iron composition 
and therefore improve the healthfulness of beef. Further studies are needed to verify the 
observed effect in other independent populations and elucidate the biological mechanisms 














This thesis is to partially fulfill the requirement of the degree of Master of Science. It is 
organized as a general literature review followed by one complete manuscript for 
submission to Animal Genetics. The review of literature introduces the background of the 
topics addressed in the manuscript in the main body of the thesis. The manuscript consists 
of seven sections, an abstract, introduction, materials and methods, results, discussion, 
acknowledgements and references. It is formatted according to the requirement of the 
journal. The manuscript is preceded by a general summary section including summary of 
results and general conclusion and future work. Then, a reference section provides the 
literature cited in the literature review and general summary section. 
Review of literature 
I. Iron and health 
Iron is an essential element for almost all living organisms. It functions as a cofactor 
for a variety of proteins in diverse biochemical processes. Iron, for example, is a vital 
component of heme in hemoglobin, myoglobin, and cytochromes (Edison et al., 2008). It 
is also an important element in iron-sulfur (Fe-S) clusters that can serve as excellent 
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electron donors and acceptors participating in electron transfer, such as in mitochondrial 
respiratory complex I – III. Moreover, Fe-S clusters function in enzyme catalysis and in 
sensing environmental or intracellular conditions to regulate gene expression, such as the 
post-transcriptional regulation by Fe-S clusters of iron regulatory protein 1 (IRP1; Lill, 
2009). Here and throughout this review of literature, iron will refer to the ionic form of 
iron in living organisms rather than elemental iron unless mentioned. 
As a redox-active transition metal, iron, however, also can be toxic at high 
concentration by generating reactive oxygen species (Andrews and Schmidt, 2007; Valko 
et al., 2005). Hence, organisms have developed a tight regulatory mechanism of iron 
homeostasis to face the challenge of obtaining adequate amounts of iron to facilitate 
biological processes and yet avoid the toxicity associated with free iron (Andrews and 
Schmidt, 2007).  
From a nutrition point of view, both iron deficiency and overload have great 
consequences and epidemiological significance (Cairo et al., 2006). Iron deficiency 
anemia, with an estimated 3 billion people affected, is still a major worldwide public 
health problem (Andrews, 2008). Hereditary hemochromatosis (HH), an iron overload 
disorder, is one of the most common genetic disorders in Caucasian population. It is also 
one of the first human genetic diseases to be linked to a discrete chromosomal position 
(Andrews, 2008). Several mutations in genes that encode proteins involved in 
maintaining iron homeostasis have been shown to be associated with HH (Table 1). 
In healthy adults, daily iron loss is estimated to be 1 mg in men and 1.5 mg in 
women, which is the result of the exfoliation, blood loss, or sweat. It can be compensated 
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by the absorption of 1-2 mg iron daily from diet (Zhang et al., 2009). Dietary iron usually 
presents in two forms: inorganic non-heme iron and organic heme iron.  
Dietary non-heme iron is present in a wide variety of foodstuffs. It is free or in weak 
complexes with other food components such as phytate or tannins during digestion (Theil, 
2004). In contrast, heme iron is in a stable porphyrin complex, whose pyrrole structure 
protects the iron against the interference from iron chelators such as polyphenols and 
phytate, which results in more efficient absorption compared with that of non-heme iron 
(Andrews, 2005).  
Heme iron is primarily from animal sources in the form of hemoglobin or myoglobin. 
Beef is a good source of dietary iron for humans and other animals in regard to both 
amount and bioavailability. It is known to be the richest source of iron compared with 
lamb, pork, chicken, and turkey (Carpenter and Clark, 1995). A 100 g portion of raw beef 
can contribute to more than 38% of the daily iron requirement of an adult 
(Giuffrida-Mendoza et al., 2007). In addition, the absorption of beef iron is efficient 
because of the high heme to non-heme iron ratio. Besides the high bioavailability of beef 
iron itself, beef consumption can enhance the absorption of dietary non-heme iron 
through the presence of “meat factor”, which may be attributed to the partially digested 
peptides from muscle proteins. These peptides were found to bind iron via their cysteine 
and histidine residues to form complexes that were soluble and available for absorption 
(Hurrell et al., 2006). Two-fold higher non-heme iron absorption was observed from 
meals that contained beef compared with the control meals with egg albumin (Cook and 
Monsen, 1976). 
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II Factors affecting iron content 
Meat exhibits natural variations in the amounts of nutrients contained therein. This 
variability could be the result of environmental and physiological factors such as age, 
muscle type, gender, species, and breed. It also could be the result of genetic factors such 
as single nucleotide polymorphisms (SNPs; Greenfield, 2003). 
Environmental and physiological factors 
Age Iron content of muscle increases with age. Doornenbal and Murray (1981) found a 
significant positive effect (P < 0.001) of age on muscle iron content with 20 mature, 
purebred Shorthorn cows ranging in age from 3 to 12 years. Rincon-Villalobos and 
Huerta-Leidenz (2007) confirmed the age effect on beef longissimus dorsi thoracis iron 
content in 64 water buffalo and 68 Zebu-influenced cattle in four age groups (7, 17, 19, 
and 24 months of age). Besides that, they also observed age by species and age by gender 
interactions that contributed to the variation of beef iron content, which ranged from 1.74 
to 2.56 mg/100 g of wet weight.  
Muscle type Mineral concentrations vary between different muscle types as a result of 
their different intensity of physical activities and the effects of muscle fiber types (Lin et 
al., 1989). Doornenbal and Murray (1981) determined iron concentration in three types of 
muscle—the longissimus dorsi, semimenbranosus, and diaphragm muscle—among 96 
animals with an age range of 421-492 days. Iron content was significantly different 
among the three muscle types. Longissimus dorsi had significantly lower iron 
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concentration than did the other two, whereas diaphragm had the highest iron content. 
Gender Beef iron concentration has not been reported to be influenced by gender, though 
several other minerals were found to be affected, including calcium, zinc, magnesium, 
sodium, and potassium (Doornenbal, 1981). Gender effect on iron content, however, has 
been reported in pork. Wiseman and his colleagues (2007) determined iron content of 
pork in two genders at various body weight intervals from 20 to 125 kg. Iron content was 
found to be greater in gilts than in barrows.  
Breed of sire Similar to that of gender, the effect of breed is not pronounced for beef iron 
content. Other minerals such as calcium, zinc, and potassium were significant different 
among breeds (Doornenbal, 1981). Consistent with the result found in cattle, another 
study showed no difference of the iron content in longissimus dorsi muscle in two breeds 
of goat (Park, 1988). 
Diet The effect of dietary iron on beef iron content is significant. Variation in the total 
iron concentrations of beef was observed for groups of calves fed different amount of 
dietary iron. Muscle heme pigment concentrations also were found to be different at 
slaughter (Miltenburg et al., 1992). According to Shenk et al. (1934), grass or grass plus 
grain feeding can increase the myoglobin content of beef compared with feeding only 
grain. 
Interaction between elements Interactions between elements affect the mineral 
concentration in beef adversely. The interactions has been found between cadmium and 
zinc and between copper and iron in hens, ruminants, and humans (Anke et al., 1970). 
The changes caused by the interactions could be explained by the functions of some metal 
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transporters on the surface of epithelial cells that do not show exclusive substrate 
preferences. Divalent metal transporter 1 (DMT1) is known as an iron transporter protein 
that imports iron into the cell, whereas manganese also is considered to be a potential 
substrate for the same transporter. In a rat model, a mutation, which rendered DMT1 
ineffective, not only caused severe anemia but also decreased tissue manganese 
concentration (Chua and Morgan, 1997). Hansen et al. (2009) investigated the effects of 
dietary iron on manganese absorption in 24 weaned pigs fed three different amounts of 
iron supplementation. They found duodenal manganese concentrations were greater in 
low iron treatment group than that in high iron treatment group. Their result suggested a 
competition between iron and manganese for DMT1. Recently, the same research group 
reported that growing beef calves with severe deficiency of copper not only showed 
decreased iron status but also showed alterations in the expression of certain iron 
regulatory genes which encoded hepcidin, ferroportin, and intestinal ferritin (Hansen et al., 
2010). 
Genetic factors 
Single nucleotide polymorphisms (SNPs) are considered to be the most common 
polymorphisms and potentially responsible for most of the phenotypic variations present 
(Vignal et al., 2002). A SNP is a DNA sequence variation that occurs when a single base 
change with a typical alternative of two possible nucleotides at the given position (Weller, 
2001). 
Genetic mutations can give rise to two types of SNPs: purine-purine or 
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pyrimidine-pyrimidine exchanges that are called transitions or pyrimidine-purine or 
purine-pyrimidine exchanges that are called transversions. Observed data showed a bias 
for SNPs towards the transitions (Collins and Jukes, 1994). SNPs may be found within 
the coding sequences of genes, non-coding sequences of genes, or in the intergenic 
regions between genes. A SNP in a coding sequence of a gene does not necessarily affect 
the amino acid sequence of the produced protein, because of the degeneracy of the 
genetic code. Then, the SNP is termed as synonymous mutation (also called silent 
mutation). Otherwise, it is called non-synonymous mutation. SNPs that are not in 
protein-coding regions, especially those in the 5’ or 3’ untranslated regions (UTRs), may 
still have consequences for exon recognition during pre-mRNA splicing and mRNA 
stability.  
SNPs are very useful as molecular markers. A SNP identified in a functional gene 
region may likely be the causal mutation or the source of phenotypic variation (Salisbury 
et al., 2003). In addition, SNPs are present throughout many genomes at a high frequency 
(Carlson et al., 2001; Konfortov et al., 1999)  
Genetic influence on iron content variation in human is indicated by inherited 
disorders such as hereditary hemochromatosis (HH), which is characterized by systemic 
iron overload. Most cases of HH in humans are believed to be the result of homozygosity 
for the C282Y mutation in the hemochromatosis gene (HFE), which encodes the human 
hemochromatosis protein (HFE). As most quantitative characteristics with a genetic 
component seem to be affected by multiple genes, Whitfield et al. (2000) did an 
association assessment in a human cohort study to compare the effect of HFE 
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polymorphism with other genetic factors in body iron variation. Their results suggested 
significant effects from other unknown genes on iron storage. They also provided 
evidence for the necessity of a further search for polymorphisms in iron homeostasis 
related genes. Mutations in any of the genes which encode proteins involved in iron 
regulation, iron absorption, iron utilization, and iron storage have the potential to alter 
iron load (Constantine et al., 2009). In different strains of inbred mice, SNPs in the 
promoters of hepcidin were found to be correlated with iron-loading variations (Bayele 
and Srai, 2009). In human cohort studies, serum iron status has been found to be 
significantly associated with SNPs in the genes encoding bone morphogenetic protein 2 
(BMP2; Milet et al., 2007), duodenal cytochrome b (Cybrd1; Constantine et al., 2009), 
transferrin (Tf; Benyamin et al., 2009b), and transmembrane protease, serine 6 
(TMPRSS6; Benyamin et al., 2009a).  
III. Iron hemeostasis 
Intestinal iron absorption 
Body iron is mainly obtained from the diet. The iron absorption takes place primarily 
in the proximal portion of the duodenum. Normally, there is little or no paracellular iron 
transport. Iron, thus, must be transported across both the apical and basolateral 
membranes of the enterocytes to enter the circulation (Andrews, 2008). 
Most dietary non-heme iron is in the bio-unavailable ferric (Fe3+) form, which must 
be reduced to ferrous (Fe2+) form for transport. This process is facilitated by brush border 
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ferrireductase (Figure 1). The first intestinal ferrireductase to be identified is duodenal 
cytochrome b (Cybrd1; McKie et al., 2001). However, Cybrd1 knock-out mice did not 
show any apparent disorder, which suggested the existence of other mechanisms for iron 
reduction (Gunshin et al., 2005b). Later, another ferrireductase— six-transmembrane 
epithelial antigen of the prostate 3 (Steap3) was found, which is important for transferrin 
(Tf)-transferrin receptor 1 (TfR1)-mediated iron uptake in erythroid cells.  
DMT1 serves as the primary transmembrane iron transporter (Gunshin et al., 1997), 
bringing the reduced Fe2+ into the enterocytes. The crucial role of DMT1 has been 
confirmed by targeted mutation of the murine DMT1 gene (Gunshin et al., 2005a). Once 
the iron enters the epithelial cells, a large portion is transported across the basolateral 
membrane of the enterocytes, which is considered as absorbed. A small portion is 
retained in the enterocytes and stored in ferritin, a major iron storage protein. The retained 
iron is lost during enterocytes senescence and sloughed into the gut. Ferroportin (Fpn) is 
currently the only known protein responsible for cellular iron export (Abboud and Haile, 
2000; Donovan et al., 2000; McKie et al., 2000). Iron is exported in Fe2+ form, which 
needs to be oxidized to Fe3+ form before binding to serum transferrin. The oxidation of 
Fe2+ to Fe3+ is facilitated by multicopper ferroxidases including serum protein 
ceruloplasmin (Cp) and membrane-bound intestinal hephaestin (Cherukuri et al., 2005; 
Vulpe et al., 1999). Cp is also found to be necessary for maintaining Fpn activity on the 
cell surface (De Domenico et al., 2007a).  
Though the absorption of non-heme iron is understood in some detail, that of heme 
iron, which is mainly from animal source, remains uncertain (Andrews, 2008). Recently, 
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heme uptake was found to be mediated by heme carrier protein 1 (HCP1) which is 
localized on the brush-border membrane in the proximal duodenum (Shayeghi et al., 
2005). It is proposed that, after heme is transported into the enterocytes by HCP1, iron is 
liberated from the protoporpyrin ring by heme oxygenase and joins the same intracellular 
pathway as non-heme iron (Andrews, 2005). 
In the circulation system, nearly all absorbed iron bind rapidly to transferrin (Tf), an 
abundant extracellular protein with high iron-binding affinity (Cheng et al., 2004). Tf 
keeps iron nonreactive and soluble, delivering it through circulation and extravascular 
fluid to tissues for utilization or storage. 
Iron utilization 
The largest user of iron is the erythroid bone marrow. Tf-mediated endocytosis via 
TfR1 is considered to be the most important way for iron uptake in developing erythroid 
precursors. The acidic environment in the endosome leads to iron release from Tf. 
Released Fe3+ is reduced to Fe2+ by Steap3 and then transported into the cell by DMT1 
(Hentze et al., 2004). Although TfRs are ubiquitously expressed, most non-hematopoietic 
tissues can assimilate iron without the TF cycle (Andrews and Schmidt, 2007). 
Once iron is inside the cell, it can be directed towards mitochondria where the 
critical steps of heme synthesis and Fe-S cluster biogenesis take place or it can be stored 
in ferritin, an cellular iron storage protein. Heme snythesis mainly takes place in 
mitochondria, with the intermediate steps occurring in the cytosol (Ponka, 1997). 
Mitogerrin serves as the mitochondrial iron importer (Shaw et al., 2006).  
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Skeletal muscle is another large user of iron. Human skeletal muscle represents 
about 40% of body mass and contains around 10% to 15% of body iron, which is mainly 
in myoglobin. However, little is known about the iron assimilation in skeletal muscle 
(Robach et al., 2007).  
Regulation of iron homeostasis 
Iron is essential for the fundamental aspect of cellular function, but it is also toxic in 
excess by generating reactive oxygen species. Iron homeostasis, therefore, needs to be 
maintained meticulously from the process including iron transport, utilization, and storage. 
Regulatory mechanisms have been identified for keeping cellular and systemic iron 
balance (Hentze et al., 2004).  
At the cellular level, one of the regulatory mechanisms is through ferritin, a 
ubiquitous iron storage protein. Ferritin acts as a buffer which can bind iron at iron 
overload and allow for iron mobilization when needed (Theil, 2003). The other protective 
mechanism is post-transcriptional regulation through the interaction between iron 
responsive elements (IREs) and iron regulatory proteins (IRPs). IREs are stem and loop 
structures localized in the 5’ or 3’ UTRs of mRNAs. It can be recognized and bound by 
IRPs at low iron condition. During iron overload, IRP2 is ubiquitinated and degraded 
(Iwai et al., 1998), whereas IRP1 is assembled with a Fe-S cluster, which prevents IRE 
binding and converts IRP1 to a cytosolic aconitase (Rouault et al., 1991). Depending on 
the location of IREs, the interaction between IRPs and IREs serves different roles 
(Pantopoulos, 2004; Pantopoulos and Hentze, 1998). IRE/IRP complexes formed in the 5’ 
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UTR of an mRNA inhibit translation. These IREs has been identified for the mRNAs 
encoding ferritin heavy and light chains (FTH1 and FTL), erythroid 5-aminolevulinic acid 
synthase, mitochondrial aconitase, and Fpn. (Muckenthaler et al., 1998). A second type of 
IREs is located at the 3’ UTR of mRNA encoding TfR1. IRP-binding can stabilize the 
mRNA through protecting it against the nuclease digestion (Hentze and Kuhn, 1996). The 
interaction between IRPs and IREs is regulated by the cellular iron pool as well as some 
other factors such as reactive oxygen species (Pantopoulos and Hentze, 1998). 
Iron homeostasis need also to be maintained systemically throughout the body. 
Systemic iron homeostasis involves the need to balance among intestinal iron absorption, 
iron utilization, iron recycling, and iron storage (Andrews, 2008).  
Hepcidin, a peptide hormone produced by hepatocytes, is mainly responsible for 
modulating systemic iron homeostasis (Nicolas et al., 2001). Hepcidin is a 25-amino-acid 
protein that primarily is secreted by the liver but also is produced in heart, pancreatic, and 
hematopoietic cells (Peyssonnaux et al., 2006). Its importance is established by several 
observations: 1. Hepcidin expression increases when excess iron is administered (Pigeon 
et al., 2001); 2. Forced expression of a hepcidin transgene causes anemia (Nicolas et al., 
2002); and 3. Targeted mutation of HAMP (the hepcidin gene) causes severe iron 
overload (Viatte et al., 2005). It is reported that hepcidin regulates intestinal iron 
absorption and macrophage iron release by the control of cellular iron export through Fpn 
(Nemeth et al., 2004). In vitro studies showed that hepcidin can bind directly to cell 
surface Fpn, inducing Fpn internalization and ubiquitin-mediated degradation (De 
Domenico et al., 2007b). In the small intestine, inactivation of Fpn leads to the retention 
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of iron in the intestinal epithelium without absorption. In the macrophage where iron 
recycling and storage take place, removal of Fpn from the cell surface causes interrupted 
release of iron (Andrews, 2008).  
The transcription of HAMP is activated by the bone morphogenetic protein 
(BMP)/SMAD pathway. Liver-specific disruption of SMAD4 led to significant decrease 
of hepcidin expression and iron accumulation in many organs (Wang et al., 2005). In 
addition, Babitt et al. (2007) showed BMP2 could positively regulate hepcidin expression 
in vivo. Recently, BMP6 was identified as a master hepcidin regulator, which indicated a 
critical role of BMP6 in iron homeostasis (Meynard et al., 2009). 
Iron-loading disorders 
Iron-loading disorders mainly include iron deficiency anemia, hemochromatosis, and 
the anemia of chronic disease. Many of them are inherited iron disorders (Table 1). 
Hereditary hemochromatosis (HH) is defined as an iron-loading disorder caused by a 
genetically determined failure to prevent unneeded dietary iron from entering the 
circulatory pool and is characterized by progressive hepatic parenchymal iron overload 
with the potential for multiorgan damage and disease (Pietrangelo, 2006). It is usually 
inherited in an autosomal-recessive pattern, with a high prevalence up to 1 in 100 
individuals in northern European populations (Merryweather-Clarke et al., 2000). Little 
was known about the molecular basis of HH until 1996 when Feder and his colleagues 
(1996) discovered a mutation (C282Y) in hemochromatosis gene (HFE) in the majority of 
hemochromatosis patients. Till now, mutations have been identified in many other genes 
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that encode proteins involved in iron homeostasis. 
The molecular pathogenesis of HH can be divided into three categories. The first one 
is the mutations in HAMP, disturbing the production of functional hepcidin protein. 
Hepcidin, with critical importance in the regulation of iron homeostasis, also is 
considered to play a central role in the pathogenesis of HH (Roetto et al., 2003). The 
second category involves the mutations in the genes encoding HFE (HFE; Feder et al., 
1996), TfR2 (TfR2; Camaschella et al., 2000), and hemojuvelin (HFE2; Papanikolaou et 
al., 2004), resulting in depressed hepcidin expression. The last group is the mutations in 
the Fpn gene, which cause Fpn insensitive to hepcidin regulation or Fpn subcellular 
mislocalization and thus lead to HH (Montosi et al., 2001; Njajou et al., 2001). 
IV. Ferroportin 
General description 
Ferroportin (Fpn, also known as IREG1, and MTP1), which was discovered 
simultaneously by three different research groups, is the only currently known cellular 
iron exporter protein found in vertebrates (Abboud and Haile, 2000; Donovan et al., 2000; 
McKie et al., 2000). It shares no homology with either iron importer DMT1 or other 
mammalian proteins. Ferroportin is a multipass integral membrane protein. A topological 
structure model provided by Rice et al. (2009) shows Fpn with 12 transmembrane 
domains and both N and C termini in the cytoplasmic side. The oligomeric state of Fpn is 
an issue still under debate. Evidence from different sources indicates the possible 
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existence of monomers, dimers, or multimers.  
Fpn is reported to be present in all cell types that export ferrous iron including 
enterocytes, macrophages, white blood cells involved in erythrophagocytosis, Kupffer 
cells, brain astrocytes, and placental cells. In addition, Fpn is highly expressed on the 
surface of cells with high iron export capacity, especially in enterocytes and tissue 
macrophages (Abboud and Haile, 2000; Donovan et al., 2000; McKie et al., 2000). 
Fpn plays a crucial role as the only cellular iron exporter. Evidence from Fpn 
knockout mouse study showed an early failure in embryonic development, suggesting the 
importance of Fpn in the transport of iron from extra-embryonic visceral endoderm prior 
to placental formation. Intestine-specific inactivation of Fpn resulted in severe iron 
deficiency, which confirmed the essentiality of Fpn in the intestinal iron absorption 
(Donovan et al., 2005).   
Ferroportin regulation 
Ferroportin expression is controlled by two regulatory mechanisms: 
post-transcriptional regulation by IRP/IRE interaction and post-translational regulation by 
hepcidin.  
Ferroportin mRNA is reported to bear a functional IRE motif in its 5’ UTR (McKie 
et al., 2000). Overexpression of Fpn in tissue culture cells resulted in IRP1 activation 
(Abboud and Haile, 2000). The binding of IRP to IREs at the 5’ UTR blocks the initiation 
of translation by interfering with ribosome assembly at the start codon. This IRP/IRE 
regulation ensures that the expression of Fpn is repressed in low iron conditions to 
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maintain cellular iron balance (Leipuviene and Theil, 2007).  
Galy et al (2008) provided evidence for the significance of IRP-mediated 
post-transcriptional control of Fpn expression in the duodenum. In mice lacking intestinal 
IRP expression, they found a great enhancement of Fpn expression under normal mRNA 
abundance, accompanied with increased expression of negative regulator hepcidin. 
Recently, Zhang et al. (2009) reported a Fpn transcript that was expressed by utilizing an 
alternative upstream promoter in duodenal epithelial and erythroid precursor cells. This 
transcript of Fpn lacked the 5’ IREs and was not repressed in low iron conditions, which 
suggested a way for Fpn to bypass IRP-dependent regulation.  
Besides translational regulation by IRP/IRE interaction, Fpn expression also is 
controlled by hepcidin-mediated post-translational regulation, which is also the major 
mechanism for maintaining whole-body iron homeostasis. Hepcidin is a peptide hormone, 
which is primarily produced by hepatocytes and secreted into the circulation system. The 
human HAMP gene encodes an 84-residue prepropeptide with a 24-residue N-terminal 
signal peptide, which is under subsequential cleavage to produce pro-hepcidin. Mature 
hepcidin is a 25-amino-acid peptide that is processed from pro-hepcidin. Mass 
spectrometry and chemical analysis showed 8 cysteine residues in the peptide, all in 
disulfide bonds, which suggested a highly constrained structure of hepcidin (Park et al., 
2001). Mutations of HAMP led to systemic iron overload or hemochromatosis (Nemeth et 
al., 2004). Hepcidin binds directly to Fpn, triggering Fpn phosphorylation, internalization, 
and consequently ubiquitin-mediated degradation. The removal of Fpn from cell surface 
blocks iron efflux and decreases serum iron concentration. Fpn is the major protein 
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through which hepcidin regulates serum iron abundance and tissue iron distribution 
(Nemeth et al., 2004).  
Phosphorylation and ubiquitination are two protein modifications known to signal 
the internalization of membrane proteins (Bonifacino and Traub, 2003). Phosphorylation 
of Fpn is the primary event in response to hepcidin binding, which occurs rapidly on the 
cell surface. It is a critical signal for clathrin-coated pits mediated internalization. Two 
adjacent tyrosine residues, Y302 and Y303, were identified to be the phosphorylation site 
on Fpn. Mutation of both tyrosine residues to phenylalanine prevented hepcidin-mediated 
Fpn internalization but did not affect Fpn localization (De Domenico et al., 2007b). In 
addition, the src kinase inhibitor inhibited hepcidin-mediated tyrosine phosphorylation, 
internalization, and degradation of Fpn, which indicated that the tyrosine kinase that 
phosphorylated Fpn belonged to the src kinase family. The topological structure of Fpn 
has not been conclusively resolved, and it remains to be determined what conformational 
change occurs during Fpn and hepcidin interaction. Several working models have been 
proposed. One model proposed by Liu et al. (2005) shows that the two tyrosines Y302 
and Y303 are located between transmembrane regions VI and VII, facing the cytoplasm, 
whereas another model provided by Rice et al. (2009) places the two tyrosines in the 
middle of transmembrane region VI, which is not directly accessible to cytosolic kinases. 
They suggested a conformational shift during the binding of hepcidin to the extracellular 
loop of Fpn, which exposes the tyrosine residues to the cytosol for phosphorylation.  
Ubiquitination of Fpn takes place subsequently to internalization that is required for 
trafficking and degradation. Lysine residue K253 on the cytosolic side of Fpn was found 
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to be the site for ubiquitination. Mutation of K253 resulted in a protein with no 
ubiquitination that was degraded at a much slower rate than was the wide type, even 
though the mutant protein was properly targeted to the cell surface, phosphorylated, and 
internalized in response to hepcidin (De Domenico et al., 2007b). According to the model 
proposed by Liu et al. (2005), the identified ubiquitination site is on the same cytosolic 
loop as the phosphorylation sites, which suggests a relationship between ubiquitination 
and phosphorylation. Fpn is trafficked to the lysosome after unbiquitination. This process 
depends on the multivesicular body (MVB) pathway and requires participation of all three 
endosome sorting complex required for transport (ESCRT) complexes and late-acting 
accessory factors (De Domenico et al., 2007b). 
In summary, the regulation of Fpn involves the coordination of both the IRE/IRP 
network and the hepcidin regulatory system. IRP-controlled post-transcriptional 
regulation of Fpn reflects cellular iron balance, whereas the post-translational regulation 
performed by hepcidin reflects systemic iron requirements (Muckenthaler et al., 2008). 
Moreover, though there is no known regulatory mechanism for iron excretion, regulation 
of iron transport through Fpn in intestinal enterocytes implicates an explanation. Body 
iron deficiency increases Fpn expression, which allows for increased intestinal absorption 
and recovery of iron from intestinal epithelium. On the other hand, body iron overload 
decreases Fpn expression, thus increases the amount of iron retained in enterocytes, 
which is lost into the lumen during enterocyte exfoliation (Donovan et al., 2005). 
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Ferroportin-linked iron-loading disorder 
Ferroportin-linked iron loading disorder is referred to as type IV HH (“ferroportin 
disease”). The first mutation related to this disease was identified simultaneously by two 
research groups in 2001 (Montosi et al., 2001; Njajou et al., 2001). Till now, several Fpn 
mutants have been identified (Figure 2), all of which cause missense changes and exert 
their disease phenotype in an autosomal dominant fashion. Some mutations were found to 
develop hyperferritinaemia with high ferritin but low transferrin saturation and mostly 
macrophage/Kupffer cell iron loading (Pietrangelo, 2004), whereas others have 
abnormalities similar to typical HH with high transferrin saturation, and hepatocyte iron 
loading (Sham et al., 2005). 
Based on the molecular basis of the ferroportin disease, the mutants with 
heterogenous phenotypes as mentioned above can be divided into two categories. One 
group shows loss of iron export function, including Fpn mutant Δ162, Δ160-162, G323V, 
and G490D. The defect in the iron export function is resulted from the subcellular 
mislocalization of Fpn, even though the protein expression profile is similar to that of the 
wild type. The mutant Fpn, instead of localizing to the cell surface, was found to be 
primarily intracellularly trapped in the endoplasmic reticulum. The lack of membrane 
expression of Fpn results in the loss of iron export function and also the loss of interaction 
with hepcidin. This reduction in cellular iron efflux is reflected by the high ferritin in cells 
and iron overload in tissues that require the largest iron flows (i.e., macrophages) In 
contrast, the second group of Fpn mutants retained full iron export activity but does not 
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appropriately respond to hepcidin regulation. For example, mutant N144H shows 
resistance to hepcidin regulation. This mutant Fpn has no hepcidin-induced degradation, 
even though hepcidin binding is not altered. It is suggested that N144H mutation might 
disrupt the Fpn domain that is required for internalization and degradation. On the other 
hand, another mutant Q182H shows normal membrane localization and hepcidin-induced 
degradation, but the internalization was delayed. More detailed mechanism remains to be 
characterized (De Domenico et al., 2005). 
V. Concluding remarks 
During the past decade, knowledge in understanding mammalian iron transport and 
its regulation has substantially increased. Many key proteins involved in regulating iron 
homeostasis have been identified and their molecular functions, though still under 
intensive study, have been partially elucidated. A combination of insights into cellular 
iron balance and systemic iron homeostasis will facilitate our understanding of the 
signaling mechanism of local and whole-body management of iron need. Fpn is of great 
interest because of its critical role as the only known cellular iron exporter and as the 
receptor for hepcidin, which reflect the coordination between cellular iron balance and 
systemic iron homeostasis. All the progress made will lead to a better understanding of 
the molecular basis and hereditary nature of iron disorders, potentially contributing to 




Table 1. Genes involved in inherited human iron disorders (Adopted from Andrews, 2008). 
Protein  
(gene symbol) 
Protein function Disease (caused by loss-of-function 
mutations unless otherwise noted) 
Ceruloplasmin 
(Cp) 
Plasma ferroxidase Aceruloplasminemia 
DMT1 
(SLC11A2) 
Transmembrane iron importer Anemia with hepatic iron overload 
Ferritin H 
chain (FTH1) 
Subunit of iron storage protein; 
has ferroxidase activity 




Subunit of iron storage protein Hyperferritinemia-cataract syndrome 




Transmembrane iron exporter Macrophage-predominant iron overload 
(Loss-of-function mutation that cause 
protein mislocalization) 
  Hemochromatosis (gain-of-function 
mutation that cause insensitivity to 
hepcidin) 
Frataxin (FXN) Mitochondrial iron chaperone Friedreich ataxia 
Glutaredoxin 5 
(GLRX5) 
Participates in Fe-S cluster 
biogenesis 









Iron regulatory hormone, binds 
ferroportin to cause its 
inactivation and degradation 
Juvenile hemochromatosis 
HFE (HFE) Regulates hepcidin expression, 
mechanism uncertain; interacts 
with TFR1 and TFR2; may 
participate in a signaling 
complex with TFR2 
Classic HLA-linked hemochromatosis 
Mitoferrin 
(SLC25A37) 
Mitochondrial iron import Erythropoietic protoporphyria 
Transferrin 
(TF) 
Plasma iron binding protein, 





Sensor for diferric transferrin; 
regulates hepcidin expression; 
may participate in a signaling 





Figure 1. A generic mammalian cell depicted to illustrate cellular iron import, utilization, and 
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We hypothesized that genetic polymorphisms in ferroportin (Fpn), which encodes 
the only known cellular iron exporter, could influence muscle iron content. The objective 
of this study was to identify single nucleotide polymorphisms (SNPs) in the exons and 
flanking regions of the bovine Fpn gene and to evaluate the extent to which they were 
associated with beef iron content. Longissimus dorsi (LD) muscle samples were collected 
from 1086 Angus cattle for iron quantification and DNA extraction. All exons and their 
flanking regions of Fpn were amplified and sequenced with 6 selected DNA samples for 
SNP identification. Genotyping with the identified SNPs were carried out for the 1086 
cattle. Nine novel SNPs, NC007300: g.1780 A>G, g.1872 A>G, g.7169 C>T, g.7477 C>G, 
g.19208 C>T, g.19263 A>G, g.19427 A>G, g.19569 C>T and g.20480 C>T, were 
identified, among which SNP g.19208 C>T, g.19263 A>G, and g.20480 C>T were 
significantly (P < 0.007) associated with muscle iron content. High linkage 
disequilibrium was observed for SNP g.19208 C>T, g.19263 A>G, and g.20480 C>T (R2 
> 0.99) with which two haplotypes, TGC and CAT, were defined. Beef from individuals 
that were homozygous for the TGC haplotype had significantly (P < 0.001) higher iron 
content than did beef from CAT homozygous or heterozygous individuals. In conclusion, 
SNPs, NC007300: g.19208 C>T, g.19263 A>G, and g.20480 C>T might be useful 
markers for the selection of Angus cattle that produce progeny with a more desirable iron 
composition. Further studies are needed to verify the observed effect in other independent 
populations and elucidate the biological mechanism of the SNP effects. 
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Introduction 
Iron, an essential element, is required as an ionic cofactor for a variety of proteins 
and functions as an excellent biological electron donor and acceptor (Edison et al., 2008; 
Lill, 2009). However, iron deficiency anemia, with an estimated 3 billion people affected, 
is still a major worldwide public health problem (Andrews, 2008). Beef is a good source 
of dietary iron in regard to both amount and bioavailability (Purchas et al., 2003). 
As a redox-active transition metal, iron, though important physiologically, is toxic 
at high concentration by generating reactive oxygen species (Galaris et al., 2008). Iron 
homeostasis, thus, must be maintained systemically by the rate of iron absorption through 
the duodenal mucosa, the rate of iron release from storage, and the rate of iron utilization. 
There is no paracellular iron transport under normal circumstances. So iron needs the 
assistance of transporter proteins to cross the cell membrane. Among several identified 
iron transporters, ferroportin (Fpn) is the only known iron exporter, which facilitates iron 
transport out of a cell (Abboud and Haile, 2000; Donovan et al., 2000; McKie et al., 
2000). In addition, Fpn is the receptor of hepcidin, a peptide hormone that acts as the 
central regulator of serum iron concentration. Binding of hepcidin to Fpn leads to Fpn 
internalization and degradation and consequently decreases the iron efflux into the plasma 
(De Domenico et al., 2007). Evidence from Fpn knockout mouse study showed an early 
failure in embryonic development, which indicated an important role of Fpn in 
maternoembryonic iron transfer (Donovan et al., 2005). Intestine-specific inactivation of 
Fpn resulted in severe iron deficiency, which confirmed the essentiality of Fpn in the 
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intestinal iron absorption (Donovan et al., 2005). Fpn is reported to be highly expressed 
on the surface of skeletal muscle cells. The expression of muscle Fpn also is regulated by 
serum hepcidin concentration (Robach et al., 2009). 
Iron content in beef is known to vary with physiological and environmental factors, 
such as animal age, muscle type (Doornenbal, 1981), diet (Shenk et al., 1934) and 
interaction between elements (Anke et al., 1970). Influence from genetic factors is 
indicated by inherited disorders such as hereditary hemochromatosis (HH) which is 
characterized by systemic iron overloadi (Le Gac and Ferec, 2005). Most cases of HH in 
human were believed to be the result of polymorphisms in hemochromatosis gene (HFE). 
However, it appears that most quantitative characteristics with genetic components are 
affected by multiple genes. Whitfield et al. (2000) compared the effect of HFE 
polymorphisms and other genetic factors on the variation of iron stores and showed 
considerably greater effects from other unknown genes on iron stores in addition to HFE. 
It is suggested that mutations in any of the genes encoding proteins in iron regulation, 
iron absorption, iron utilization, and iron storage have the potential to alter iron load 
(Constantine et al., 2009). Till now, several proteins have been reported to be associated 
with HH besides HFE, including hemojuvelin, transferrin receptor-2 (TfR2), and Fpn. 
Mutations in human Fpn gene cause systemic iron overload, which is referred to as type 
IV hereditary hemochromatosis (“ferroporotin disease”; Cazzola, 2003; Pietrangelo, 
2004). Besides the disease-related mutations, more than six hundred SNPs, mostly in 
human and mice, have been identified in the coding and non-coding regions of Fpn. To 
our knowledge, no SNPs have been reported for Fpn in cattle yet. Moreover, skeletal 
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muscle, which contains 10 to 15% of body iron in human, is of great interest regarding 
iron homeostasis (Robach et al., 2007). However, little is currently known about the 
genetic factors that may influence iron storage in cattle, especially in skeletal muscle.  
Growing evidence shows that polymorphisms in genes that encode a component of 
the iron regulation network potentially can influence whole-body iron content. In addition, 
Fpn plays an important role in the maintenance of iron homeostasis. Therefore, we 
hypothesized that variation in Fpn gene among individuals would be a candidate for 
heritable differences in iron content of skeletal muscle and might be used as markers to 
improve the healthfulness of iron content in beef while maintaining other positive 
physical and chemical attributes of the food product. 
In this study, we identified nine novel single nucleotide polymorphisms (SNPs) 
mostly in the flanking regions of bovine Fpn exons. We then evaluated the relationship 
between Fpn genotype and iron content of LD muscle in Angus cattle and observed 
significant associations between the three SNPs and the iron content of beef. 
Materials and Methods 
Animals and sample collection 
Angus cattle (n=1086) were used in this study. The cattle consist of 391 young 
bulls, 181 steers and 154 heifers from Iowa State University Angus breeding project 
(Ames, Iowa) and 360 steers from collaborators in California. All of the cattle were raised 
with no implants and no antibiotic treatment. They were harvested at commercial 
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facilities with an average age of 457 ± 46 days. Longissimus dorsi muscle samples were 
collected, trimmed of external connective tissue and adipose tissue, freeze ground, packed, 
and stored at -20oC until iron concentration analysis. 
Iron concentration analysis 
Beef samples were dried, and moisture was determined according to AOAC official 
method 934.01 (2005). Dry samples were subjected to closed-vessel microwave digestion 
process (CEM, MDS-2000) with 5 mL concentrated nitric acid and 2 mL 30% hydrogen 
peroxide according to AOAC official methods 999.10 (Jorhem and Engman, 2000). 
Microwave programs were set as following: 250 watts for 5 min, 630 watts for 5 min, 500 
watts for 20 min, and 0 watts for 15 min. Total iron concentration in beef was determined 
by using inductively coupled plasma-optical emission spectroscopy (ICP-OES, 
SPECTRO Analytical Instruments). 
DNA polymorphism identification and genotyping 
Genomic DNA was purified by phenol chloroform method. Six DNA samples, half 
from cattle with high muscle iron and half from cattle with low muscle iron, were selected 
for SNP identification. Eight pairs of PCR primers were designed to amplify the nine 
exons and their adjacent intronic regions of Fpn gene (Table 1). The product sizes for the 
eight sets of primers were 965, 1000, 927, 677, 799, 799, 831, and 682 bp, respectively. 
The PCR mixture contained 12.5 ng genomic DNA, 500 nM of each primers, 5 μL 
GoTaq® colorless master mix (1.5 mM MgCl2, 0.2 mM dNTP mixture, and GoTaq® DNA 
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polymerase; Promega) at a final volume of 10 μL. The PCRs were performed in a DNA 
engine thermal cycler (Bio-Rad) with the following protocol: 94 oC for 5 min; followed 
by 39 cycles of 94 oC for 30 s; 58 oC for 35 s, and 72 oC for 35 s; with a final extension 
step at 72 oC for 5 min. PCR products were purified using ExoSAP-IT® (USB). The DNA 
sequences of PCR amplicons were determined with ABI 3730 DNA Analyzer (Applied 
Biosystems Inc.) at the Iowa State University DNA Facility. The genotypes of the 
identified SNPs in the 1086 Angus cattle were determined by Sequenom® at Genomic 
Technologies Core Facility at Iowa State University.  
Statistical analysis  
Data were analyzed by using a mixed linear model (PROC MIXED; SAS Inst., Inc.) 
according to the following statistical model: 
Yijklm = μ + Si + Cj (Si) + Ak + Gl + Gl × Si + Sirem + eijklm, 
Where, 
Yijklm = dependent variable (beef iron concentration); 
μ = overall mean; 
Si = fixed effect of the ith level of source (i = 1, 2); 
Cj (Si) = fixed effect of the jth level of contemporary group nested with in ith level 
of source (j = 1 – 19); 
Ak = age as covariance of the kth observation (k = 1 – 1086); 
Gl = Fixed effect of the lth level of genotype in the genotype as class effect model (l 
= 1, 2, 3), 
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or  
genotype (homozygote AA = -1, heterozygote AB = 0, and homozygote BB = 1) as 
covariance of the lth observation in the allele substitution model; 
Gl × Si = interaction term of the lth genotype with the ith source; 
Sirem = random effect of sire of observation m; sirem ∼ N(0, σs2); 
eijklm = random error term; eijklm ∼ N(0, σe2). 
Significance threshold correction for multiple comparisons was determined with 
the method developed by Cheverud (2001). After adjustment, P values that were less or 
equal to 0.007 were determined to be significant, and P values that were between 0.007 to 
0.014 were classified as statistical tendencies. Least square means (±SE) were determined 
by using the genotype as class model as defined above. Mean values were compared by 
using pairwise t-tests. Additive genetic effect of each locus was estimated as the 
difference between the two homozygous groups. The dominance effect was estimated as 
the difference between the heterozygous group and the average of the two homozygous 
groups in each locus (Khatib et al., 2007). The haplotype and linkage disequilibrium were 
analyzed by using Haploview (Barrett et al., 2005). 
Results 
DNA polymorphism identification and selected nucleotide sequence alignment 
Bovine Fpn is located on chromosome 2. The gene is 23,683 bp in length, with 
nine exons. We amplified and sequenced the nine exons of Fpn and their flanking regions 
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of six Angus cattle. Nine nucleotide substitutions were identified, which were NC007300: 
g.1872 A>G, g.7169 C>T, g.7477 C>G, g.19208 C>T, g.19263 A>G, g.19427 A>G, 
g.19569 C>T, and g.20480 C>T. Two SNPs, g.19427 A>G and g.20480 C>T were located 
in the exons. SNP g.19427 A>G in exon 7 was predicted to result in an amino acid 
replacement from methionine (ATG) to valine (GTG) and the other one, g.20480 C>T in 
exon 8, was a synonymous mutation.  
The rest of the SNPs were in intronic regions, four of which were located close to 
exons. Polymorphism g.7169 C>T was -6 nt from the beginning of exon 4, SNP g.19208 
C>T and g.19263 A>G were located -80 and -26 nt upstream of exon 7, respectively. SNP 
g.19569 C>T was +36 nt downstream of exon 7. Nucleotide sequence alignments were 
carried out by using BLAST (http://www.ncbi.nlm.nih.gov/blast) for g.7169 C>T, 
g.19208 C>T, g.19263 A>G, and g.20480 C>T among cattle, human, chimpanzee, 
monkey, house mouse, and rat (Figure 1). All of the four polymorphisms were found to be 
conserved among these species and also in conserved noncoding or coding sequences. 
Genotype frequencies of the identified SNPs 
Angus cattle (n = 1086 head) were genotyped with the nine identified SNPs. Most 
of the SNPs were in Hardy-Weinberg Equilibrium, except g.7169 C>T and g.19263 A>G. 
SNP g.1780 A>G, g.1872 A>G, g.7169 C>T, and g.7477 C>G showed a low minor allele 
frequency that is less than 3%, in which g.1780 A>G showed a rare allele with frequency 
less than 1% (Table 2). For SNP g.19208 C>T, g.19263 A>G, g.19427 A>G, g.19569 C>T, 
and g.20480 C>T, approximately half of the cattle were heterozygous. 
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Nearly complete linkage disequilibrium was observed among SNP g.19208 C>T, 
g.19263 A>G, and g.20480 C>T (R2 > 0.99), which defined two haplotypes, TGC and 
CAT, with frequency 61.1% and 38.6%, respectively (Figure 2). 
Association of SNP genotype with iron content of LD muscle 
With the genotype result, we tested for the association between the nine SNPs 
identified and muscle iron content. Five SNPs were found to have P-value less than 0.05. 
After adjustment for multiple comparisons, P values that less than 0.007 are considered to 
be statistically significant. Three SNPs, g.19208 C>T, g.19263 A>G, and g.20480 C>T, 
were strongly (P < 0.007) associated with iron content after the adjustment both in the 
genotypic as class effect model and allele substitution model. Polymorphism g.7477 C>G, 
tended (P < 0.014) to be associated with iron content in the genotypic as class effect 
model (Table 3). No significant associations were detected between the iron content and 
SNP g.1780 A>G, g.1872 A>G, g.7169 C>T, g.19427 A>G, and g.19569 C>T. Similar 
results were obtained for both cattle from Iowa and those from California. As a result, we 
only present the combined analysis. 
Three genotypes were significantly (P < 0.005) associated with high beef iron 
content compared with other genotypes. They were TT genotype in 19208, GG genotype 
in 19263 and CC genotype in 20480.  
Moreover, as mentioned above, SNP g.19208 C>T, g.19263 A>G, and g.20480 C>T 
were in almost complete linkage disequilibrium (R2 > 0.99) and defined two haplotypes, 
TGC and CAT (Table 4). Homozygote with TGC or CAT haplotype had frequency of 
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39.87% or 16.40%, respectively, and the frequency for the heterozygote was 43.73%. The 
association analysis between the haplotypes and beef iron content showed that beef from 
individuals that were homozygous for the TGC haplotype had significantly (P < 0.001) 
higher iron contents than did beef from CAT homozygous or heterozygous individuals. 
Contribution of Fpn genotype to iron content of LD muscle 
Additive and dominant effect were tested for haplotype TGC and CAT in SNP 
g.19208 C>T, g.19263 A>G, and g.20480 C>T (Table 4). Significant (P < 0.005) additive 
effect was observed for this haplotype block. 
Discussion 
Fpn is the only identified cellular iron exporter that plays an important role in 
maintaining iron homeostasis. Currently, over 600 SNPs have been reported for mainly 
human and mice in the coding and non-coding regions of Fpn, but none for cattle. In this 
study, nine novel SNPs, NC007300: g.1780 A>G, g.1872 A>G, g.7169 C>T, g.7477 C>G, 
g.19208 C>T, g.19263 A>G, g.19427 A>G, g.19569 C>T, and g.20480 C>T, were 
identified in the exons and their flanking regions of Fpn. Comparison between the SNPs 
identified in this study and the known SNPs of Fpn in NCBI SNP database showed no 
similarity.  
In addition, strong associations between the identified SNPs and beef iron content 
were found in this study. Among the identified SNPs, g.19208 C>T, g.19263 A>G, and 
g.20480 C>T were associated significantly (P < 0.007) with the iron content. SNP g.7747 
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C>T tended (P < 0.014) to be associated with LD muscle iron content. With the growing 
understanding of the molecular basis of iron regulation, several mutations have been 
reported in human Fpn gene that link with iron overload disorders, which is referred to as 
type IV hereditary hemochromatosis (“ferroporotin disease”; Cazzola, 2003; Pietrangelo, 
2004). All identified mutations in Fpn are missense mutations that lead to amino acid 
substitutions or deletions (De Domenico et al., 2005). Moreover, several studies either in 
human or in mice were conducted to relate variation in body iron status with 
polymorphisms in iron-related genes. In human cohort studies, serum iron status was 
found to be associated significantly with polymorphisms in genes that encode bone 
morphogenetic protein 2 (BMP2; Milet et al., 2007), duodenal cytochrome b (CYBRD1; 
Constantine et al., 2009), transferrin (TF; Benyamin et al., 2009b), and transmembrane 
protease, serine 6 (TMPRSS6; Benyamin et al., 2009a). In different strains of inbred mice, 
SNPs in the promoter region of hepcidin were found to be correlated with iron-loading 
difference (Bayele and Srai, 2009). No association between iron status and Fpn has been 
reported yet. To our knowledge, this was the first study addressing the association 
between genetic polymorphisms in Fpn and variation of muscle iron content.  
The three SNPs, g.19208 C>T, g.19263 A>G, and g.20480 C>T, were significantly 
(P < 0.007) associated with beef iron content were of great interest. They were in nearly 
complete linkage disequilibrium and defined two haplotypes. 
 SNP g.19208 C>T and g.19263 A>G were located -81 and -26 nt upstream of the 
exon 7, respectively. SNP g.20480 C>T, though located in coding region, was not 
predicted to cause amino acid replacement. The location of this SNP, however, was of 
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great significance, because it was in exon 8, which encodes an important domain of Fpn. 
In human, this domain bears the hepcidin binding sites (Residue 324-343), 
phosphorylation sites (Y301 and Y302), and ubiquitination site (K253). Binding of 
hepcidin to Fpn leads to Fpn phosphorylation, internalization, ubiquitination and 
degradation. (De Domenico et al., 2009; De Domenico et al., 2007). Nucleotide sequence 
alignment among several species showed that the three SNPs were in conserved 
sequences. It has been suggested that similarities in coding and non-coding sequences 
between divergent organisms imply functional constraint. Therefore, the result from the 
nucleotide sequence alignment may indicate certain functional role for SNP g.19208 C>T, 
g.19263 A>G, and g.20480 C>T. 
The efficiency of mRNA splicing site recognition is a combinatorial control of 
several parameters, such as splice site strength, the presence or absence of splicing 
enhancers and silencers, RNA secondary structures, and the exon/intron architecture. 
Mutations that affect these parameters potentially may influence pre-mRNA processing 
and consequently protein expression (Hertel, 2008). Exonic splicing enhancers (ESEs) are 
cis-acting RNA sequence elements located within exons that can increase exon inclusion 
by serving as binding sites for the assembly of multicomponent splicing enhancer 
complexes (Black, 2003). With online bioinformatics tool—ESE Finder (Cartegni et al., 
2003; Smith et al., 2006), SNP g.20480 CC genotype was predicted to be in a putative 
alternative splicing factor/splicing factor 2 (ASF/SF2) binding site (GAGACGG), which 
was lost if the genotype was changed from C to T. Therefore, it is possible that SNP 
g.20480 C>T, though a synonymous mutation, would influence the function of Fpn via 
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the interference of the splicing efficiency of exon 8 as a part of ESE. 
SNP g.19208 C>T and g.19263 A>G were located in the upstream close to exon 7. 
With an on-line alternative splice site predictor (Wang and Marin, 2006), SNP g.19263 
A>G was found to be a few nucleotides away from a putative RNA splicing site. In 
addition, this polymorphism was not in Hardy-Weinberg equilibrium, which potentially 
indicates selection at this site. Mammalian RNA splicing is known to be regulated by 
cis-acting elements, either as enhancer or silencer. In human amyloid precursor protein 
gene, Shibata et al (1996) identified two cis-acting elements, ATGTTT and TTT, 
involved in the modulation of RNA splicing in the human APP gene. The two 
cis-elements found were in the upstream of exon 8, one as enhancer, and the other one as 
silencer. In the current study, the g.19208 locus was in a TTT sequence that might be 
involved in a cis-acting element, thereby potentially regulating the efficiency of the intron 
excision, whereas this explanation need to be taken cautiously, because the RNA splicing 
regulation may have tissue/cell-type specificity or depending on developmental stage 
(Pozzoli and Sironi, 2005). It is reported also that secondary structure may be part of the 
“mRNA splicing code” that determines exon recognition, though it remains unclear which 
motifs (loop or stem) are more favored by trans-acting factors (Hiller et al., 2007). As 
TTT is a stem-forming sequence, nucleotide replacement within this sequence would 
disrupt the secondary structure of pre-mRNA, which might consequently affect the 
following mRNA splicing. 
Thus, the polymorphism in these loci might be able to influence the iron content of 
muscle via the interference of the efficiency of mRNA splicing recognition. Although 
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currently there is no evidence supporting the role for the three SNPs in Fpn expression, a 
possible involvement cannot be ruled out. High linkage disequilibrium observed for these 
three SNPs may be another explanation for the strong associations. It is also possible that 
they are in linkage disequilibrium with other causative mutations that have not been 
identified yet. Verification of the effect of these SNPs in other cattle populations is 
important to confirm the associations before they can be applied to marker-assisted 
selection. 
SNP g.1780 A>G had low minor allele frequency of less than 1%. However, during 
the genetic association analysis, the only animals with g.1780 GG genotype was dropped 
off because of lacking sire information. Therefore, no association analysis had been done 
for g.1780 GG genotype. Future research is needed to investigate the effect of this rare 
allele on muscle iron content. 
Besides SNP g.1780 A>G, SNP g.1872 A>G, g.7169 C>T and g.7477 C>G had 
also low minor allele frequency of 0.01, 0.03, and 0.01, respectively. The association 
analysis of these SNPs need to be interpreted cautiously because of the limited data on 
these genotypes as well as their large standard error. 
 Interestingly, polymorphism g.19427 A>G in exon 7, was predicted to cause 
codon change from ATG to GTG which consequently changed an amino acid from 
methione to valine. However, the iron content of LD muscle was not statistically 
associated with this amino acid change. Sequence alignment performed among cattle, 
human, orangutan, chimpanzee, mouse, and rat showed that this site was conserved across 
all these species (data not shown). 
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In conclusion, nine novel SNPs in Fpn, NC007300: g.1780 A>G, g.1872 A>G, 
g.7169 C>T, g.7477 C>G, g.19208 C>T, g.19263 A>G, g.19427 A>G, g.19569 C>T, and 
g.20480 C>T, were identified in this study. SNP g.19208 C>T, g.19263 A>G, and 
g.20480 C>T are strongly associated with beef iron content, which might be useful 
markers for facilitating the selection of Angus cattle with more desirable LD muscle iron 
content and therefore to improve the healthfulness of beef. Further investigations are 
needed to verify the observed effect in other independent cattle populations and elucidate 
the biological mechanisms of the SNP effect. 
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Table 1. Primer sequences. 
 Sequence 
Primer name Forward Reverse 
Fpn-1 TGAGGACTCCTTGATGACGA ATGGGACAGGCAGTTACCAG 
Fpn-2 GCCTTTCCAACTTCAGCTACA CACTAACACCTATGGGAAAACATC 
Fpn-3 CTTGACATCCAAGGCATACTGA TCCAATGCAAGTCCTGGTTA 
Fpn-4 AATACGGTCGTTACGAATGG GATCTGAAAGCTAGCAACTGGA 
Fpn-5 CAGATGTGACCAAGCACTCA ACCCACATCTCTCGCATCTC 
Fpn-6 TCATGAAGATGGGAAGCGTA GTTCAACCCAGATTTGTTCCA 
Fpn-7 TGTGCCCTCCATAGGTGA GCTGAATTATCTGACCCTCCA 




















Table 2. Polymorphisms in Fpn exons and adjacent introns and genotype frequency. 
g.1780 A>G g.1872 A>G g.7169 C>T 
Variable 
AA AG GG AA GA GG CC CT TT 
Number of animals 479 31 1 802 237 15 25 216 779
Genotype frequency 0.94 0.06 0.00 0.76 0.23 0.01 0.03 0.21 0.76
g.7477 C>G g.19208 C>T g.19263 A>G 
Variable 
CC CG GG CC TC TT AA GA GG
Number of animals 16 272 824 157 486 412 161 457 437
Genotype frequency 0.01 0.25 0.74 0.15 0.46 0.39 0.15 0.43 0.42
g.19427 A>G g.19569 C>T g.20480 C>T 
Variable 
AA AG GG CC CT TT CC CT TT 
Number of animals 139 362 234 117 266 157 377 503 167































Table 3. Single SNP genotypic and allelic association with beef iron content 
P-valuea for association test 
SNP Number of animals 
Genotypic Allelic 
g.1780 A>G 470 0.4850 0.7986 
g.1872 A>G 971 0.1056 0.0984 
g.7169 C>T 935 0.0267 0.0118 
g.7477 C>G* 1020 0.0133 0.0437 
g.19208 C>T** 963 0.0003 < 0.0001 
g.19263 A>G** 964 0.0022 0.0006 
g.19427 A>G 662 0.9301 0.7509 
g.19569 C>T 499 0.5665 0.6959 
g.20480 C>T** 953 0.0016 0.0005 
aP-values were not corrected for multiple comparisons 
*P-value < 0.014 





























Table 4. Effects of Fpn SNPs on LD muscle iron content.1 
 
1 Values are expressed as least square means ± SE. Iron content are expressed as μg per gram of wet weight of longissimus dorsi muscle. 







g.1780 A>G g.1872 A>G 
Traits 
AA  AG  GG  AA  AG  GG  
Iron content 13.42 ± 0.21 13.54± 0.52 N.A. 13.25 ± 0.15 12.81 ± 0.21 13.39 ± 0.75 
g.7169 C>T g.7477 C>G 
Traits 
CC  CT  TT  CC CG  GG  
Iron content 13.55 ± 0.64 13.59 ± 0.22 13.03 ± 0.15 11.15 ± 0.74 13.04 ± 0.20 13.26 ± 0.14 
g.19208 C>T g.19263 A>G 
Traits 
CC  CT  TT  AA  AG  GG  
Iron content 12.69 ± 0.25a 12.92 ± 0.16a 13.53 ± 0.17b 12.79 ± 0.25a 13.00 ± 0.17a 13.54 ± 0.17b 
g.19427 A>G g.19569 C>T 
Traits 
AA  AG  GG  CC  CT  TT  
Iron content 13.20 ± 0.27 13.18 ± 0.21 13.10 ± 0.24 13.26 ± 0.29 13.58 ± 0.24 13.42 ± 0.29 
g.20480 C>T    
Traits 
CC  CT  TT     
Iron content 13.54 ± 0.17a 12.95 ± 0.16b 12.77 ± 0.25b    
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Table 5. Effect of haplotypes of genotype g.19208 C>T, g.19263 A>G, and g.20480 C>T on LD 
muscle iron content and estimates (±SE) of additive and dominant effect associated with the 
haplotypes. 
Genotype 






TT GG CC 372  39.87 13.51A ± 0.16
CT AG CT 408  43.73 13.00B ± 0.15
CC AA TT 153  16.40 12.80B ± 0.23
Haplotype additive effect 0.76 ± 0.25*** 
Haplotype dominant effect -0.18 ± 0.17 
1 Values are expressed as LSmeans ± SE. Iron content are expressed as μg per gram of wet 
weight of longissimus dorsi muscle. 
A, B Values with different subscripts differ at P < 0.001. 
































Figure 1. Nucleotide sequence alignments for g.7169 C>T, g.19208 C>T, g.19263 A>G, and 
g.19569 C>T among several mammalian species. The multiple sequence alignments were carried 
out by using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The nucleotide polymorphism loci 
are shown in bold and in red. 
 
g.7169 C>T 
GTCAGCACCTTTTCTCCTGTCCTGTTTCCAGGGGGACCGGATGTGGCACT 7170      Cattle 
ATCAAAACATTTTCT-CT-TTTCATTTA-AGGGAGATCGGATGTGGCACT 10487     Human 
ATCAAAACATTTTCT-CT-TTTCATTTA-AGGGAGATCGGATGTGGCACT 8456      Chimpanzee 
ATCAAAACATTTTCT-CT-TTTCATTTA-AGGGAGATCGGATGTGGCACT 9640      Monkey 
AACCAAACATCTTTC----TTTTGTTTA-AGGGGGATCGGATGTGGCACT 4275      House mouse 




ACA-------GTTAATCAATACACTTGGTTTA-TGAGTTGCGTTATGTAC 19241     Cattle 
ATG-------TCTAATCTATACTCTTGGTTTACAGCTTTGTATTGTGTAA 20164     Human  
ATGCAAAATGTCTAATCTATACTCTTGGTTTACAGCTTTGTATTGTATAA 18627     Chimpanzee 
ATG-------GCTAATCTGTACTCTTGGTTTACAGGTTTGTATTGTGTAA 18768     Monkey 
ATG-------GTTAGTCTGTACTGTTGGTTT--AGATTTATAGCACATAA 13075     House mouse  
ATG-------GATGGTCTGCACTGTTGGTTT--AGACTTATAGCACGTAA 13390     Rat 
 
g.19263 A>G 
TCTCTTTGATAGATTTGCACACTTGCCTGCCTTTTTCACCTATCTCTGTA 19291     Cattle 
TCTCTTTGATGGGTTTGCACACTTACCTGCCTCTTTCACCTGCCTCTCTA 20214     Human 
TCTCTTTGATGGGTTTGCACACTTACCTGCCTCTTTCACCTGCCTCTCTA 18677     Chimpanzee  
----TTTGATGGGTTTGTACACTTACCTGCCTCTTTCACCTGCTTCTCTA 18816     Monkey  
TGTAACTCT----------CACTTACCTGCCTCTTGCACCTACCTGTGTA 13115     House mouse 
TTTCTTTCACAGTTTGGAACGCTCACTCTCCTCTTTCACCTACTTC--TA 13438     Rat 
 
g.20480 C>T 
TGAGCCCTTCCGCACTTTCCGAGACGGATGGGTCTCCTATTACAACCAGT 20505     Cattle 
TGAGCCCTTCCGTACCTTCCGAGATGGATGGGTCTCCTACTACAACCAGC 21742     Human 
TGAGCCCTTCCGTACCTTCCGAGATGGATGGGTCTCCTACTACAACCAGC 20200     Chimpanzee 
TGAGCCCTTCCGTACCTTCCGAGATGGATGGGTCTCCTACTACAACCAGC 20353     Monkey  
AGAGCCCTTCCGCACTTTCCGAGATGGATGGGTCTCCTACTATAACCAGC 14220     House mouse 

































Summary of results and general conclusion 
In the current study, I investigated the effect of genetic factor, single nucleotide 
polymorphisms (SNPs), on the iron content of beef longissimus dorsi (LD) muscle.  
The dual role of iron, essential but toxic at high concentration, requires cellular and 
systemic regulation of iron homeostasis. Muscle iron content is affected by physiological 
and environmental factors including age (Giuffrida-Mendoza et al., 2007), muscle type 
(Doornenbal, 1981), and diet (Miltenburg et al., 1992), and it is also affected by genetic 
factors. Several human cohort studies have shown that the serum iron status was 
significantly associated with polymorphisms in iron-related genes (Constantine et al., 
2009; Milet et al., 2007), (Benyamin et al., 2009a; Benyamin et al., 2009b). In this study, 
I focused on one candidate gene, ferroportin (Fpn), which encodes the only known 
cellular iron exporter. Nine novel SNPs, NC007300: g.1780 A>G, g.1872 A>G, g.7169 
C>T, g.7477 C>G, g.19208 C>T, g.19263 A>G, g.19427 A>G, g.19569 C>T, and 
g.20480 C>T, were identified in the exons and their flanking regions of Fpn. Except 
g.19427 A>G and g.20480 C>T, all of the SNPs identified were located in intronic region. 
Nucleotide sequence alignment using BLAST showed that SNP NC007300: g.7169 C>T, 
g.19208 C>T, g.19263 A>G, and g.20480 C>T, were conserved among cattle, human, 
chimpanzee, monkey, house mouse, and rat (http://www.ncbi.nlm.nih.gov/blast). 
Genotypes of the 1086 Angus cattle were obtained for the 9 novel SNPs, and effect 
of the 9 identified SNPs on muscle iron content was analyzed. SNP g.19208 C>T, 
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g.19263 A>G, and g.20480 C>T were found to be significantly associated (P < 0.007) 
with the iron concentration in bovine LD muscle. It is noticeable that the three SNPs were 
conserved among species and SNP g.19208 C>T and g.19263 A>G were located -81 and 
-26 nt upstream of exon 7, respectively. To preliminarily investigate the mechanism of 
the strong association observed between iron content and SNP g.19208 C>T and g.19263 
A>G., I used an on-line alternative splice site predictor (Wang and Marin, 2006) and 
found SNP g.19263 A>G to be a few nucleotides away from a putative RNA splicing site. 
In addition, this polymorphism was not in Hardy-Weinberg equilibrium, which potentially 
indicates selection at this site. We also found that SNP g.19208 C>T was in a sequence 
pattern that was reported to be a cis-acting element (Shibata et al., 1996). The observation 
indicated that SNP g.19208 C>T and g.19263 A>G could potentially regulate the 
efficiency of intron excision, and consequently influence muscle iron content. It is also 
reported that exonic splicing enhancers (ESEs) are cis-acting RNA sequence elements 
located within exons that can increase exon inclusion by serving as binding sites for the 
assembly of multicomponent splicing enhancer complexes (Black, 2003). With online 
bioinformatics tool—ESE Finder (Cartegni et al., 2003; Smith et al., 2006), SNP g.20480 
CC genotype was predicted to be in a putative alternative splicing factor/splicing factor 2 
(ASF/SF2) binding site (GAGACGG), which was lost if the genotype is changed from C 
to T. Therefore, it is possible that SNP g.20480 C>T, though a synonymous mutation, 
would influence the function of Fpn via the interference of the splicing efficiency of exon 
8 as a part of ESE. 
In addition, polymorphism g. 19208 C>T, g.19263 A>G, and g.20480 C>T were in 
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nearly complete linkage disequilibrium, which defined two haplotypes, TGC and CAT. 
Association analysis for this haplotype block showed that beef from individuals that were 
homozygous for the TGC haplotype had significantly (P < 0.001) higher iron contents 
than did beef from CAT homozygous or heterozygous individuals. 
In conclusion, results of the current study indicated that SNPs, NC007300: g.19208 
C>T, g.19263 A>G, and g.20480 C>T in Fpn might be useful markers for facilitating the 
selection of Angus cattle with high LD muscle iron content and therefore to improve the 
healthfulness of beef.  
Future work 
1. The mechanism of the SNP effects 
In this study, we found strong associations between three SNPs identified and 
muscle iron content. Two of them were in introns and one in an exon without causing 
nucleotide replacement. To explain the observed association, we preliminarily analyzed 
whether they are conserved by sequence alignment among species and analyzed their 
possible interference with RNA splicing using the bioinformatics tools available online. 
However, these tools are limited because they performed the function based on available 
information for mRNA and genomic DNA sequence alignments, whereas biological 
mechanisms may vary among species, cell types, and even different development stages 
(ElSharawy et al., 2009). Therefore, systematic and hypothesis-driven in vivo and in vitro 
experiments are needed to investigate the effect of the putatively splicing-relevant SNPs. 
The elucidation of the mechanism of how the SNPs affect muscle iron content would be a 
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great improvement to the understanding of the molecular basis of Fpn function and iron 
variation and enrich our knowledge of RNA splicing mechanisms. 
2. SNPs in other iron regulation proteins in beef 
Skeletal muscle is of great importance regarding whole body iron homeostasis. It is 
estimated that, in human beings, skeletal muscle represents about 40% of body mass and 
contains 10% to 15% body iron that is mainly located in myoglobin (Robach et al., 2009). 
However, little attention has been given to the molecular physiology of iron homeostasis 
in skeletal muscle. The regulation of iron homeostasis could be different in muscle than in 
other tissues when considering the high amount of myoglobins and their unique function. 
Bovine muscle may be used as a model to understand the regulation of iron utilization 
and storage in muscle. In addition, several gene polymorphisms that are linked with 
serum iron status have been found in iron homeostasis-related genes, such as BMP2 
(Milet et al., 2007), CYBRD1 (Constantine et al., 2009), TF (Benyamin et al., 2009b), and 
TMPRSS6 (Benyamin et al., 2009a). Investigations are needed for the associations 
between gene polymorphisms in iron-related proteins and the muscle iron content. 
Moreover, beef is a good source of dietary iron in regard to both amount and 
bioavailability. A 100 g portion of raw beef would provide an adult with more than 38.2% 
of daily iron requirement. Therefore, it would be of great interest to improve the 
healthfulness of beef from the aspect of iron contents. Identification of SNPs in other 
iron-related proteins and investigations of their effect on muscle iron content will 
contribute to our understanding of muscle iron regulation and also will be useful for 
developing marker-assisted selection of cattle that can produce progeny with more 
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desirable muscle iron content.  
3. The association between SNPs and other minerals 
Besides that of iron, the content of many other essential elements are known to vary 
in beef (Doyle, 1980). Mechanisms of some mineral-loading disorders indicated genetic 
influence, including disorders for zinc, magnesium, and copper. It is of great interest to 
know the effect of SNPs in the content of minerals other than iron. Mineral content can be 
measured in bovine muscle and SNPs can be identified on the genes related to mineral 
homeostasis. Association analysis can be carried out with SAS.  
4. Breed effect on LD muscle iron content 
In this study, Angus cattle were used for the identification of SNPs. However, it 
will be beneficial if the SNPs identified in Angus cattle can be applied also to other 
breeds of beef cattle. Though previous study showed little breed effect on iron content of 
muscle (Doornenbal, 1981), future systematic studies are needed to compare the LD 
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